Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.88p
   
  • Change Today:
      0.18p
  • 52 Week High: 17.00
  • 52 Week Low: 8.15
  • Currency: UK Pounds
  • Shares Issued: 927.98m
  • Volume: 214,593
  • Market Cap: £91.64m

Latest ShareCast News

Scancell appoints healthcare finance veteran as new CFO

By Josh White

Date: Tuesday 29 Aug 2023

(Sharecast News) - Immunotherapy developer Scancell announced the appointment of Sath Nirmalananthan as its new chief financial officer on Tuesday, effective immediately.

Scancell to present positive recent findings at oncology summit

By Josh White

Date: Friday 02 Jun 2023

(Sharecast News) - Immunotherapy developer Scancell said on Friday that it is set to present an informative poster at the American Society of Clinical Oncology Meeting (ASCO) 2023 annual meeting in Chicago from 2 to 6 June.

Scancell shares jump on positive cancer vaccine progress

By Josh White

Date: Tuesday 21 Feb 2023

(Sharecast News) - Immunotherapy developer Scancell announced the completion of the monotherapy dose-finding arm of the phase 1 and 2 'ModiFY' clinical trial on Tuesday.

Scancell licenses Vaccitech IP for its next vacc... 07-Nov-2022 ShareCast
Scancell enrols and doses first patient in lates... 31-Oct-2022 ShareCast
Scancell losses widen on expense of ongoing trials 28-Oct-2022 ShareCast
Scancell inks licensing deal with Nasdaq-traded ... 25-Oct-2022 ShareCast
Scancell presents new, positive data on possible... 23-Sep-2022 ShareCast
Scancell developing 'promising' new cancer treat... 23-Jun-2022 ShareCast
Scancell updates protocol for UK trial in melano... 15-Jun-2022 ShareCast
Scancell opens recruitment for cancer therapy tr... 11-Apr-2022 ShareCast
Scancell treats first patient in melanoma tumour... 19-Nov-2021 ShareCast
Scancell gets MHRA approval for Modi-1 clinical ... 26-Aug-2021 ShareCast
Scancell chooses needle-free tech for Covid vacc... 17-Aug-2021 ShareCast
Scancell makes progress with 'Covidity' trial pl... 22-Jun-2021 ShareCast
Scancell ends clinical development partnership w... 03-Feb-2021 ShareCast
Scancell selects Covid-19 vaccine candidate for ... 18-Dec-2020 ShareCast
Scancell reaches Covid-19 collaboration agreemen... 02-Oct-2020 ShareCast
Scancell upbeat on publication of AvidiMab resea... 12-Jun-2020 ShareCast
Director dealings: Scancell director lowers stake 28-Apr-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 9.88p
Change Today 0.18p
% Change 1.80 %
52 Week High 17.00
52 Week Low 8.15
Volume 214,593
Shares Issued 927.98m
Market Cap £91.64m

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
9.63% below the market average9.63% below the market average9.63% below the market average9.63% below the market average9.63% below the market average
1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average
Price Trend
61.99% below the market average61.99% below the market average61.99% below the market average61.99% below the market average61.99% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for 10-May-2024

Time Volume / Share Price
11:20 2,944 @ 10.19p
11:02 981 @ 10.19p
09:16 4,121 @ 10.19p
09:12 100,000 @ 9.65p
08:38 54,408 @ 10.19p

SCLP Key Personnel

CEO Lindy Durrant
CFO Sath Nirmalananthan

Top of Page